Al Janaby, Tina, Said Khelwatty, Izhar Bagwan, Nima Abbassi-Ghadi, and Helmout Modjtahedi. “Co-Expression of HER2 EGFRvIII CD44 and Claudin 18.2 CD109 As Novel Prognostic Indicators in Stomach Adenocarcinoma”. World Journal of Oncology (April 5, 2025). Accessed April 6, 2025. https://wjon.elmerpub.com/wjon/article/view/2552.